Literature DB >> 3994472

Acute oxalate nephropathy after massive ascorbic acid administration.

J M Lawton, L T Conway, J T Crosson, C L Smith, P A Abraham.   

Abstract

A single 45-g dose of intravenous ascorbic acid, a metabolic precursor of oxalate, was administered to a patient as adjuvant therapy for primary amyloidosis and the nephrotic syndrome. Acute oliguric renal failure occurred. Postmortem histopathologic examination of renal tissue revealed extensive intratubular deposition of crystalline material, which was confirmed as calcium oxalate by a microincineration technique. There were no extrarenal deposits of calcium oxalate. Plasma oxalate and ascorbic acid concentrations were increased. We conclude that therapy with high-dose ascorbic acid is a potential cause of oxalate nephropathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994472

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.

Authors:  Anitra C Carr; Patrice C Rosengrave; Simone Bayer; Steve Chambers; Jan Mehrtens; Geoff M Shaw
Journal:  Crit Care       Date:  2017-12-11       Impact factor: 9.097

Review 2.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.

Authors:  Carmel Jacobs; Brian Hutton; Terry Ng; Risa Shorr; Mark Clemons
Journal:  Oncologist       Date:  2015-01-19

4.  Vitamin C-induced oxalate nephropathy.

Authors:  Jorge Lamarche; Reji Nair; Alfredo Peguero; Craig Courville
Journal:  Int J Nephrol       Date:  2011-03-16

5.  Any Role of High-Dose Vitamin C for Septic Shock in 2021?

Authors:  Ankita Agarwal; David N Hager; Jonathan E Sevransky
Journal:  Semin Respir Crit Care Med       Date:  2021-09-20       Impact factor: 3.921

6.  Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Authors:  Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

7.  Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro.

Authors:  J Dötsch; S Demirakça; A Cryer; J Hänze; P G Kühl; W Rascher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 8.  Ascorbic acid intake and oxalate synthesis.

Authors:  John Knight; Kumudu Madduma-Liyanage; James A Mobley; Dean G Assimos; Ross P Holmes
Journal:  Urolithiasis       Date:  2016-03-22       Impact factor: 3.436

9.  Oxalic acid excretion after intravenous ascorbic acid administration.

Authors:  Line Robitaille; Orval A Mamer; Wilson H Miller; Mark Levine; Sarit Assouline; David Melnychuk; Caroline Rousseau; L John Hoffer
Journal:  Metabolism       Date:  2009-02       Impact factor: 8.694

10.  Acute Oxalate Nephropathy following Ingestion of Averrhoa bilimbi Juice.

Authors:  Sreeja Nair; Jacob George; Sajeev Kumar; Noble Gracious
Journal:  Case Rep Nephrol       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.